Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

In this study, investigators compared genome sequencing with cytogenetic analysis in 263 patients with acute myeloid leukemia or myelodysplastic syndromes. Prospective sequencing detected new genetic information that was not revealed by cytogenetic analysis in nearly 25% of the patients, which alter...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 384; no. 10; pp. 924 - 935
Main Authors Duncavage, Eric J, Schroeder, Molly C, O’Laughlin, Michele, Wilson, Roxanne, MacMillan, Sandra, Bohannon, Andrew, Kruchowski, Scott, Garza, John, Du, Feiyu, Hughes, Andrew E.O, Robinson, Josh, Hughes, Emma, Heath, Sharon E, Baty, Jack D, Neidich, Julie, Christopher, Matthew J, Jacoby, Meagan A, Uy, Geoffrey L, Fulton, Robert S, Miller, Christopher A, Payton, Jacqueline E, Link, Daniel C, Walter, Matthew J, Westervelt, Peter, DiPersio, John F, Ley, Timothy J, Spencer, David H
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 11.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this study, investigators compared genome sequencing with cytogenetic analysis in 263 patients with acute myeloid leukemia or myelodysplastic syndromes. Prospective sequencing detected new genetic information that was not revealed by cytogenetic analysis in nearly 25% of the patients, which altered the risk category for most of these patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa2024534